Related by context. Frequent words. (Click for all words.) 79 refractory chronic lymphocytic 76 metastatic castration resistant 76 liposomal formulation 75 Irinotecan 74 relapsed refractory multiple myeloma 74 multi kinase inhibitor 74 polymerase inhibitor 74 Coadministration 73 Pegasys ® 73 Initiate Phase 73 gastrointestinal stromal tumors GIST 73 Belimumab 73 leukemia CLL 73 Panzem R 72 mRCC 72 Chronic Hepatitis C 72 metastatic renal cell carcinoma 72 Epratuzumab 72 proteasome inhibitor 72 Bortezomib 72 metastatic hormone refractory 72 Gemzar ® 72 HER2 positive metastatic breast 72 Dasatinib 72 luteinizing hormone releasing 72 pertuzumab 71 DOXIL 71 relapsed multiple myeloma 71 Traficet EN 71 refractory multiple myeloma 71 R sorafenib tablets 71 Drug Candidate 71 Pivotal Phase III 71 mTOR inhibitor 71 Amrubicin 71 Ixempra 70 docetaxel chemotherapy 70 Metastatic Melanoma 70 Ofatumumab 70 Acute Myeloid Leukemia AML 70 Voreloxin 70 humanized anti 70 Lenalidomide 70 primary hypercholesterolemia 70 voriconazole 70 Monotherapy 70 superficial bladder cancer 70 elotuzumab 70 Pivotal Phase 70 refractory Hodgkin lymphoma 70 Carfilzomib 70 KRN# 70 Recombinant Human 70 Well Tolerated 70 dacarbazine 70 CHEAP ONLINE PHARMACY LOW 70 II Clinical Trial 69 J Am Acad 69 cutaneous T cell 69 plus prednisone 69 Clevudine 69 immunomodulating 69 Preclinical Data 69 forodesine 69 Completes Enrollment 69 FOLFIRI 69 alkylating agents 69 Metastatic Colorectal Cancer 69 Bevacizumab 69 chlorambucil 69 temsirolimus 69 Navelbine 69 J Am Coll 69 TELCYTA 69 fludarabine 69 HGS ETR1 69 TLR9 agonist 69 subcutaneous formulation 69 non alcoholic steatohepatitis 69 trimethoprim sulfamethoxazole 69 Laquinimod 69 anticancer compound 69 Vandetanib 69 dasatinib 69 administered subcutaneously 69 hepatitis C HCV 69 Initiates Phase 69 Copegus R 69 REVLIMID R 69 ganetespib 69 nilotinib 69 Adalimumab 69 intravenously administered 69 tyrosine kinase inhibitor 69 imatinib mesylate 69 plus dexamethasone 69 Relapsed 69 selective inhibitor 68 Taxotere ® 68 lymphoma CTCL 68 Trastuzumab